SCHEMBL14360210

SCHEMBL14360210

CC(=O)CC[C@H](CC1OCCO1)C(C)C

nearest known ligand 0.31

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11802464 0.76 ALDH1A1 (0.47) ALDH1A1
SCHEMBL14360011 0.76
SCHEMBL14359976 0.73 ALDH1A1 (0.32) ALDH1A1
SCHEMBL11234760 0.72 ALDH1A1 (0.35) ALDH1A1
SCHEMBL14342418 0.70 ALDH1A1 (0.41) ALDH1A1
SCHEMBL20961021 0.69 ALDH1A1 (0.39) ALDH1A1
SCHEMBL13835261 0.69 CA1 (0.39) ALDH1A1
SCHEMBL15274765 0.69 ALDH1A1 (0.39) ALDH1A1
SCHEMBL7706684 0.68 ALDH1A1 (0.43) ALDH1A1
SCHEMBL28977861 0.67 LMNA (0.42) ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070274928-A1 Novel Cyclic Oxygenated Compounds Having Cooling, Fragrance, and Flavor Properties, and Uses Thereof AROMAGEN CORPORATION 2007-11-29 US disclosed
US-20070274928-A1 Novel Cyclic Oxygenated Compounds Having Cooling, Fragrance, and Flavor Properties, and Uses Thereof AROMAGEN CORPORATION 2007-11-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070274928-A1 Novel Cyclic Oxygenated Compounds Having Cooling, Fragrance, and Flavor Properties, and Uses Thereof TAS2R5, KHK, TAS2R1 ALDH1A1 71/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.